COVID-19 Puts New Science to the Pressure Test
Because of the urgency to get new tests, therapies, and preventions into the clinic amid a pandemic, many of these approaches are undergoing a trial by fire
Gene Editing
Researchers Move Closer to Producing Heparin in the Lab
Heparin is a potent anti-coagulant and the most prescribed drug in hospitals, yet cell-culture-based production of heparin is currently not possible
Trends in Genetics: A Tale of Two Decades
Clifford J. Steer, MD, discusses the changes that have taken place in genomics since the sequencing of the human genome in this Q&A with contributing editor Tanuja Koppal, PhD
CRISPR-Edited Immune Cells Can Survive and Thrive after Infusion into Cancer Patients
New data on first-in-US trial sheds new light on success of gene editing and cell function
New Survey Results Reveal the Experts and Public's Attitude Toward Gene-Edited Crops
Participants for the surveys consisted of 3,197 volunteers of the lay public and scientists with and without expertise in molecular biology
Opening up DNA to Delete Disease
Custom-built molecules enable editing of genes previously obscured by DNA's innately protective structure
Horizon Discovery Signs Collaboration and License Agreement with Mammoth Biosciences
Company aims to develop the next generation of engineered CHO cell lines to improve production of biotherapeutics
Horizon Discovery to Provide Access to Novel Base Editing Technology
Next-generation gene editing system has applications in development of cell and gene therapies
ERS Genomics Announces Agreement with New England Biolabs to Commercialize CRISPR Gene Editing Tools and Reagents
License agreement expands New England Biolabs’ rights to use and sell CRISPR/Cas9 reagents and tools
A New Tomato Ideal for Urban Gardens and Even Outer Space
These new gene-edited tomato plants look nothing like the long vines you might find growing in a backyard garden or in agricultural fields